Prognostic value of pathological sensitivity for high-risk, localized prostate cancer receiving neoadjuvant hormonal therapy combined with radical prostatectomy
The difference in pathological response of PCa patients to neoadjuvant hormonal therapy has an important influence on patient survival, and can be used as an indicator to evaluate the prognosis of PCa.
Authors
- Kai Shi
- Shouzhen Chen
- Wenfu Wang (ORCID: https://orcid.org/0000-0002-3963-1649)
- Bo Han (ORCID: https://orcid.org/0000-0002-4798-7725)
- Yong Wang (ORCID: https://orcid.org/0000-0003-4707-5280)
- Xueli Wang (ORCID: https://orcid.org/0000-0002-8382-9425)
- Benkang Shi
- Yaofeng Zhu
Institutions
- Qilu Hospital of Shandong University (CN)
Publication Details
- Journal
- Annals of Medicine
- Published
- 2025-04-02
- DOI
- https://doi.org/10.1080/07853890.2025.2485399
- Citations
- 1
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 1.52
Funders
- National Natural Science Foundation of China